← Evidence map

ArticleCanadian journal of gastroenterology & hepatology

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma.

Yong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
2026
pooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35257007